Recent advances in lipoprotein metabolism and the genetic dyslipoproteinemias.

[1]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  M. Koschinsky,et al.  Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. , 1990, Biochemistry.

[3]  G. Utermann,et al.  The mysteries of lipoprotein(a). , 1989, Science.

[4]  E. Boerwinkle,et al.  Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Scott,et al.  Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. , 1988, The Journal of biological chemistry.

[6]  H. Brewer,et al.  Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[8]  J. Fruchart,et al.  Apolipoprotein A-I containing lipoproteins in coronary artery disease. , 1987, Atherosclerosis.

[9]  Z W Gu,et al.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.

[10]  H. Brewer,et al.  Identification of a novel in-frame translational stop codon in human intestine apoB mRNA. , 1987, Biochemical and biophysical research communications.

[11]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.

[12]  G. Utermann,et al.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.

[13]  J. Fruchart,et al.  Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.

[14]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[15]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[16]  H. Brewer,et al.  Two-dimensional electrophoresis of human plasma apolipoproteins. , 1984, Clinical chemistry.

[17]  A. Scanu,et al.  Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. , 1984, The Journal of biological chemistry.

[18]  C. Glueck,et al.  Primary and familial hypoalphalipoproteinemia. , 1984, Metabolism: clinical and experimental.

[19]  G. Utermann,et al.  Protein composition of Lp(a) lipoprotein from human plasma , 1983, FEBS letters.

[20]  G. Assmann,et al.  Papers and Notes on I I Methodology One-step Screening Method for the Polymorphism of Apolipoproteins A-i, A-11, and A-iv , 2022 .

[21]  G. Franceschini,et al.  Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. , 1982, The Journal of biological chemistry.

[22]  K. Berg,et al.  Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor , 1981, Clinical genetics.

[23]  G. Cazzolato,et al.  Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction. , 1980, Atherosclerosis.

[24]  S. Sasayama,et al.  Contractile Performance of the Hypertrophied Ventricle in Patients with Systemic Hypertension , 1980, Circulation.

[25]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[26]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[27]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[28]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[29]  H. Brewer,et al.  Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Miller,et al.  Clinical and metabolic aspects of high-density lipoproteins , 1984 .

[31]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[32]  H. Brewer,et al.  The plasma lipoproteins. , 1977, Advances in protein chemistry.

[33]  G. Kostner.  Lp(a) Lipoproteins and the Genetic Polymorphisms of Lipoprotein B , 1976 .

[34]  P. Alaupovic.  Conceptual Development of the Classification Systems of Plasma Lipoproteins , 1972 .